Mediwound Stock Price, News & Analysis (NASDAQ:MDWD)

$4.35 -0.15 (-3.33 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$4.35
Today's Range$4.25 - $4.45
52-Week Range$3.56 - $8.25
Volume14,800 shs
Average Volume29,299 shs
Market Capitalization$116.31 million
P/E Ratio-6.72
Dividend YieldN/A
Beta0.01

About Mediwound (NASDAQ:MDWD)

Mediwound logoMediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged tissue, known as eschar, in adults with deep partial- and full-thickness thermal burns, also referred to as severe burns. The Company sells NexoBrid in Europe and Israel. NexoBrid is a topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. Its product, EscharEx, is a topical biological drug, which is being developed for debridement of chronic and other hard-to-heal wounds. NexoBrid and EscharEx are based on its proteolytic enzyme technology. The Company is also developing an injectable product based on its proteolytic enzyme technology for connective tissue pathologies and indications.

Receive MDWD News and Ratings via Email

Sign-up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:MDWD
CUSIPN/A
Phone+972-8-9324010

Debt

Debt-to-Equity RatioN/A
Current Ratio3.58%
Quick Ratio3.46%

Price-To-Earnings

Trailing P/E Ratio-6.71875
Forward P/E Ratio-4.10
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.56 million
Price / Sales75.43
Cash FlowN/A
Price / CashN/A
Book Value$0.36 per share
Price / Book12.08

Profitability

Trailing EPS($0.64)
Net Income$-18,880,000.00
Net Margins-904.26%
Return on Equity-246.58%
Return on Assets-39.43%

Miscellaneous

Employees72
Outstanding Shares27,050,000

Mediwound (NASDAQ:MDWD) Frequently Asked Questions

What is Mediwound's stock symbol?

Mediwound trades on the NASDAQ under the ticker symbol "MDWD."

How were Mediwound's earnings last quarter?

Mediwound Ltd (NASDAQ:MDWD) issued its quarterly earnings results on Thursday, July, 28th. The biopharmaceutical company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.11. The biopharmaceutical company had revenue of $3.36 million for the quarter, compared to analyst estimates of $0.45 million. Mediwound had a negative net margin of 904.26% and a negative return on equity of 246.58%. The firm's revenue for the quarter was up 115.8% compared to the same quarter last year. During the same quarter last year, the business posted ($0.19) earnings per share. View Mediwound's Earnings History.

Where is Mediwound's stock going? Where will Mediwound's stock price be in 2018?

5 brokers have issued 12-month price objectives for Mediwound's stock. Their forecasts range from $9.00 to $11.00. On average, they expect Mediwound's stock price to reach $9.80 in the next year. View Analyst Ratings for Mediwound.

Who are some of Mediwound's key competitors?

Who are Mediwound's key executives?

Mediwound's management team includes the folowing people:

  • Stephen T. Wills CPA, Chairman of the Board (Age 59)
  • Cal Cohen, Chief Executive Officer
  • Sharon Malka, Chief Financial Officer
  • Eilon Asculai, Vice President, Research & Development
  • Lior Rosenberg, Chief Medical Officer
  • Vickie R. Driver, Director

Who owns Mediwound stock?

Mediwound's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. (8.38%), MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. (8.38%), Harel Insurance Investments & Financial Services Ltd. (2.79%), Meitav Dash Investments Ltd. (1.81%), Wells Fargo & Company MN (0.37%) and Renaissance Technologies LLC (0.37%). View Institutional Ownership Trends for Mediwound.

Who bought Mediwound stock? Who is buying Mediwound stock?

Mediwound's stock was purchased by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., Meitav Dash Investments Ltd., Wells Fargo & Company MN and Renaissance Technologies LLC. View Insider Buying and Selling for Mediwound.

How do I buy Mediwound stock?

Shares of Mediwound can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mediwound's stock price today?

One share of Mediwound stock can currently be purchased for approximately $4.35.

How big of a company is Mediwound?

Mediwound has a market capitalization of $116.31 million and generates $1.56 million in revenue each year. The biopharmaceutical company earns $-18,880,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis. Mediwound employs 72 workers across the globe.

How can I contact Mediwound?

Mediwound's mailing address is 42 Hayarkon Street, YAVNE, 8122745, Israel. The biopharmaceutical company can be reached via phone at +972-8-9324010 or via email at [email protected]


MarketBeat Community Rating for Mediwound (MDWD)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  180 (Vote Outperform)
Underperform Votes:  125 (Vote Underperform)
Total Votes:  305
MarketBeat's community ratings are surveys of what our community members think about Mediwound and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mediwound (NASDAQ:MDWD) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.80$9.80$9.80$10.33
Price Target Upside: 106.32% upside106.32% upside113.04% upside66.52% upside

Mediwound (NASDAQ:MDWD) Consensus Price Target History

Price Target History for Mediwound (NASDAQ:MDWD)

Mediwound (NASDAQ:MDWD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/8/2017OppenheimerSet Price TargetBuy$10.00HighView Rating Details
11/16/2017SunTrust BanksSet Price TargetBuy$9.00N/AView Rating Details
9/28/2017CowenInitiated CoverageOutperform$9.00MediumView Rating Details
9/28/2017Jefferies GroupReiterated RatingBuy$10.00MediumView Rating Details
5/25/2017AegisReiterated RatingBuy$11.00LowView Rating Details
8/17/2016Wells Fargo & CoInitiated CoverageOutperform$14.00N/AView Rating Details
4/23/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Mediwound (NASDAQ:MDWD) Earnings History and Estimates Chart

Earnings by Quarter for Mediwound (NASDAQ:MDWD)

Mediwound (NASDAQ MDWD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/16/2017Q3 2017($0.19)($0.16)$0.74 million$0.74 millionViewN/AView Earnings Details
8/3/20176/30/2017($0.19)($0.20)$0.69 million$0.69 millionViewListenView Earnings Details
5/8/20173/31/2017($0.17)($0.20)$0.56 million$0.54 millionViewListenView Earnings Details
2/21/201712/31/2016($0.25)($0.09)$0.73 million$0.43 millionViewListenView Earnings Details
11/14/2016Q316($0.26)($0.26)$0.61 million$0.52 millionViewN/AView Earnings Details
7/28/2016Q216($0.23)($0.34)$0.45 million$3.36 millionViewListenView Earnings Details
4/21/2016Q116($0.24)($0.17)$0.28 million$0.25 millionViewListenView Earnings Details
1/25/2016Q415($0.23)($0.36)$0.40 million$0.27 millionViewListenView Earnings Details
10/27/2015Q315($0.31)($0.17)$0.47 million$334.00 millionViewListenView Earnings Details
8/3/2015Q215($0.26)($0.19)$0.22 million$0.17 millionViewListenView Earnings Details
5/4/2015Q1 2015($0.30)($0.28)$0.18 million$0.07 millionViewListenView Earnings Details
2/12/2015Q4($0.26)($0.33)$0.10 million$0.12 millionViewListenView Earnings Details
11/5/2014Q3($0.25)($0.24)$0.31 million$0.05 millionViewListenView Earnings Details
7/31/2014Q2($0.15)($0.28)$0.19 million$0.89 millionViewListenView Earnings Details
5/2/2014Q1 2014($0.11)($0.05)$0.05 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Mediwound (NASDAQ:MDWD) Earnings Estimates

2018 EPS Consensus Estimate: ($0.48)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.11)($0.11)($0.11)
Q2 20181($0.15)($0.15)($0.15)
Q3 20181($0.12)($0.12)($0.12)
Q4 20181($0.10)($0.10)($0.10)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Mediwound (NASDAQ:MDWD)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mediwound (NASDAQ MDWD)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Mediwound (NASDAQ MDWD) News Headlines

Source:
DateHeadline
Mediwound Ltd (MDWD) Given Average Recommendation of "Hold" by AnalystsMediwound Ltd (MDWD) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - February 19 at 1:32 AM
$650,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter$650,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - February 9 at 5:44 AM
Mediwound Ltd (MDWD) Expected to Post Earnings of -$0.16 Per ShareMediwound Ltd (MDWD) Expected to Post Earnings of -$0.16 Per Share
www.americanbankingnews.com - February 7 at 5:12 AM
Mediwound Ltd (MDWD) Receives Consensus Recommendation of "Hold" from AnalystsMediwound Ltd (MDWD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 25 at 1:30 AM
Mediwound Ltd (MDWD) Expected to Post Quarterly Sales of $650,000.00Mediwound Ltd (MDWD) Expected to Post Quarterly Sales of $650,000.00
www.americanbankingnews.com - January 23 at 12:00 PM
Zacks: Analysts Expect Mediwound Ltd (MDWD) to Announce -$0.16 Earnings Per ShareZacks: Analysts Expect Mediwound Ltd (MDWD) to Announce -$0.16 Earnings Per Share
www.americanbankingnews.com - January 21 at 7:18 AM
Zacks Investment Research Lowers Mediwound (MDWD) to SellZacks Investment Research Lowers Mediwound (MDWD) to Sell
www.americanbankingnews.com - January 18 at 8:28 AM
Reviewing Mediwound (MDWD) & 3SBio (SSRX)Reviewing Mediwound (MDWD) & 3SBio (SSRX)
www.americanbankingnews.com - January 3 at 11:30 PM
Critical Comparison: Mediwound (MDWD) & Argos Therapeutics (ARGS)Critical Comparison: Mediwound (MDWD) & Argos Therapeutics (ARGS)
www.americanbankingnews.com - January 1 at 7:16 PM
Mediwound Ltd (MDWD) Receives Consensus Rating of "Buy" from AnalystsMediwound Ltd (MDWD) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - December 31 at 1:58 AM
-$0.16 Earnings Per Share Expected for Mediwound Ltd (MDWD) This Quarter-$0.16 Earnings Per Share Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - December 18 at 9:24 PM
Analyzing Ocera Therapeutics (OCRX) & Mediwound (MDWD)Analyzing Ocera Therapeutics (OCRX) & Mediwound (MDWD)
www.americanbankingnews.com - December 9 at 1:18 PM
Oppenheimer Reiterates "$10.00" Price Target for Mediwound (MDWD)Oppenheimer Reiterates "$10.00" Price Target for Mediwound (MDWD)
www.americanbankingnews.com - December 8 at 1:56 PM
$690,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter$690,000.00 in Sales Expected for Mediwound Ltd (MDWD) This Quarter
www.americanbankingnews.com - December 2 at 6:00 AM
Reviewing Kadmon (KDMN) and Mediwound (MDWD)Reviewing Kadmon (KDMN) and Mediwound (MDWD)
www.americanbankingnews.com - December 1 at 3:34 PM
MediWound Ltd. :MDWD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017MediWound Ltd. :MDWD-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 9:11 AM
MediWound Ltd. (MDWD) Upgraded to Sell at ValuEngineMediWound Ltd. (MDWD) Upgraded to Sell at ValuEngine
www.americanbankingnews.com - November 25 at 6:06 AM
MediWound Ltd. (MDWD) Lowered to "Hold" at Zacks Investment ResearchMediWound Ltd. (MDWD) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - November 24 at 12:36 AM
Equities Analysts Set Expectations for MediWound Ltd.s FY2020 Earnings (MDWD)Equities Analysts Set Expectations for MediWound Ltd.'s FY2020 Earnings (MDWD)
www.americanbankingnews.com - November 20 at 2:30 PM
MediWound Ltd. (MDWD) Given a $10.00 Price Target by Oppenheimer Holdings, Inc. AnalystsMediWound Ltd. (MDWD) Given a $10.00 Price Target by Oppenheimer Holdings, Inc. Analysts
www.americanbankingnews.com - November 18 at 1:38 PM
MediWound Ltd. (MDWD) Given a $9.00 Price Target by SunTrust Banks, Inc. AnalystsMediWound Ltd. (MDWD) Given a $9.00 Price Target by SunTrust Banks, Inc. Analysts
www.americanbankingnews.com - November 17 at 6:30 PM
MediWound Reports Third Quarter 2017 Financial ResultsMediWound Reports Third Quarter 2017 Financial Results
www.thestreet.com - November 17 at 3:57 PM
Edited Transcript of MDWD earnings conference call or presentation 16-Nov-17 1:30pm GMTEdited Transcript of MDWD earnings conference call or presentation 16-Nov-17 1:30pm GMT
finance.yahoo.com - November 17 at 3:57 PM
MediWound Ltd. (MDWD) Expected to Announce Quarterly Sales of $740,000.00MediWound Ltd. (MDWD) Expected to Announce Quarterly Sales of $740,000.00
www.americanbankingnews.com - November 14 at 10:32 AM
Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an AppealTel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal
feeds.benzinga.com - November 13 at 10:54 PM
MediWound Ltd. (MDWD) Scheduled to Post Quarterly Earnings on ThursdayMediWound Ltd. (MDWD) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - November 13 at 8:54 AM
Zacks: Analysts Expect MediWound Ltd. (MDWD) to Post -$0.19 Earnings Per ShareZacks: Analysts Expect MediWound Ltd. (MDWD) to Post -$0.19 Earnings Per Share
www.americanbankingnews.com - November 12 at 8:38 AM
MediWound to Host Third Quarter 2017 Financial Results Conference Call on November 16, 2017 at 8:30 a.m. Eastern TimeMediWound to Host Third Quarter 2017 Financial Results Conference Call on November 16, 2017 at 8:30 a.m. Eastern Time
finance.yahoo.com - November 12 at 6:02 AM
MediWound Ltd. (MDWD) Given Consensus Recommendation of "Buy" by BrokeragesMediWound Ltd. (MDWD) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 11 at 1:46 AM
Critical Analysis: MediWound (MDWD) and The CompetitionCritical Analysis: MediWound (MDWD) and The Competition
www.americanbankingnews.com - November 8 at 3:56 PM
MediWound Announces Exercise of Underwriters’ Option to Purchase Additional SharesMediWound Announces Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - October 28 at 8:03 AM
 Analysts Anticipate MediWound Ltd. (MDWD) Will Post Quarterly Sales of $740,000.00 Analysts Anticipate MediWound Ltd. (MDWD) Will Post Quarterly Sales of $740,000.00
www.americanbankingnews.com - October 25 at 11:02 PM
MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of DirectorsMediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors
finance.yahoo.com - October 25 at 7:08 AM
-$0.19 Earnings Per Share Expected for MediWound Ltd. (MDWD) This Quarter-$0.19 Earnings Per Share Expected for MediWound Ltd. (MDWD) This Quarter
www.americanbankingnews.com - October 23 at 6:24 AM
MediWound Ltd. (MDWD) Raised to Sell at ValuEngineMediWound Ltd. (MDWD) Raised to Sell at ValuEngine
www.americanbankingnews.com - October 22 at 1:32 PM
MediWound (MDWD) vs. Mirna Therapeutics (SYBX) Critical AnalysisMediWound (MDWD) vs. Mirna Therapeutics (SYBX) Critical Analysis
www.americanbankingnews.com - October 22 at 2:28 AM
Analyzing MediWound (MDWD) & The CompetitionAnalyzing MediWound (MDWD) & The Competition
www.americanbankingnews.com - October 19 at 8:28 PM
Financial Comparison: Cesca Therapeutics (KOOL) vs. MediWound (MDWD)Financial Comparison: Cesca Therapeutics (KOOL) vs. MediWound (MDWD)
www.americanbankingnews.com - October 17 at 2:08 PM
MediWound Ltd. (MDWD) Receives Consensus Recommendation of "Buy" from AnalystsMediWound Ltd. (MDWD) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - October 17 at 2:52 AM
MediWound Further Expands NexoBrids® Global Outreach Through New Distribution Agreement In Taiwan With Holy Stone HealthcareMediWound Further Expands NexoBrid's® Global Outreach Through New Distribution Agreement In Taiwan With Holy Stone Healthcare
www.thestreet.com - October 16 at 8:09 PM
MediWound Further Expands NexoBrid’s® Global Outreach through New Distribution Agreement in Taiwan with Holy Stone HealthcareMediWound Further Expands NexoBrid’s® Global Outreach through New Distribution Agreement in Taiwan with Holy Stone Healthcare
finance.yahoo.com - October 16 at 8:09 PM
Reviewing ChemoCentryx (CCXI) and MediWound (MDWD)Reviewing ChemoCentryx (CCXI) and MediWound (MDWD)
www.americanbankingnews.com - October 11 at 6:30 AM
MediWound (MDWD) vs. Its Peers Critical SurveyMediWound (MDWD) vs. Its Peers Critical Survey
www.americanbankingnews.com - October 11 at 4:32 AM
Zacks: Analysts Expect MediWound Ltd. (MDWD) Will Announce Quarterly Sales of $740,000.00Zacks: Analysts Expect MediWound Ltd. (MDWD) Will Announce Quarterly Sales of $740,000.00
www.americanbankingnews.com - October 6 at 5:58 AM
MediWound Ltd. (MDWD) Now Covered by Cowen and CompanyMediWound Ltd. (MDWD) Now Covered by Cowen and Company
www.americanbankingnews.com - September 28 at 8:18 AM
MediWound Ltd. (MDWD) Given Buy Rating at Jefferies Group LLCMediWound Ltd. (MDWD) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - September 28 at 8:00 AM
MediWound Ltd. (MDWD) Receives Average Recommendation of "Hold" from BrokeragesMediWound Ltd. (MDWD) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 23 at 12:46 AM
Research Analysts Offer Predictions for MediWound Ltd.s FY2017 Earnings (MDWD)Research Analysts Offer Predictions for MediWound Ltd.'s FY2017 Earnings (MDWD)
www.americanbankingnews.com - September 22 at 7:22 AM
Research Analysts Set Expectations for MediWound Ltd.s Q1 2018 Earnings (MDWD)Research Analysts Set Expectations for MediWound Ltd.'s Q1 2018 Earnings (MDWD)
www.americanbankingnews.com - September 20 at 8:58 AM
MediWound Secondary Capitalizes on 2017 SuccessMediWound Secondary Capitalizes on 2017 Success
247wallst.com - September 20 at 6:13 AM

SEC Filings

Mediwound (NASDAQ:MDWD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Mediwound (NASDAQ:MDWD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Mediwound (NASDAQ MDWD) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.